No Data
Haohai Biological Technology's Q1 Profit Slides 7%
HAOHAI BIOTEC (06826.HK) spent 1.67 million HKD to repurchase 0.07 million shares on April 28.
Gelonghui April 28丨HAOHAI BIOTEC (06826.HK) announced that on April 28, 1.67 million HKD was spent to repurchase 0.07 million shares.
HAOHAI BIOTEC (06826) spent 1.6695 million HKD on April 28 to repurchase 0.07 million shares.
HAOHAI BIOTEC (06826) announced that on April 28, 2025, it will spend 1.6695 million Hong Kong dollars to repurchase...
Shanghai Haohai Biological Technology (688366.SH) reported a Net income of 90.3121 million yuan in the first quarter, a decrease of 7.41% year-on-year.
Gelonghui reported on April 26 that Shanghai Haohai Biological Technology (688366.SH) released its quarterly report, achieving total operating revenue of 0.619 billion yuan in the first quarter of 2025, a year-on-year decrease of 4.25%; the Net income attributable to shareholders of the parent company was 90.3121 million yuan, down 7.41% year-on-year; the EPS was 0.39 yuan.
Shanghai Haohai Biotechnology Co., Ltd. Report for the first quarter of 2025
HAOHAI BIOTEC (06826) announced its first-quarter performance with a net profit attributable to the parent company of approximately 90.3121 million yuan, a decrease of 7.41% year-on-year.
HAOHAI BIOTEC (06826) announced its performance for the first quarter of 2025, with revenue of approximately 0.6185 billion yuan, same...
Investors Interested In Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Earnings
